Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Triclosan Causes Rapid Restructuring of Gut Microbiome

By HospiMedica International staff writers
Posted on 02 Jun 2016
Triclosan, a common antimicrobial and antifungal agent found in many consumer products, can rapidly disrupt the bacterial communities found in the digestive system, according to a new study.

Researchers at Oregon State University (OSU, Corvallis, USA) exposed 45 adult zebrafish to triclosan-laden food for four or seven days or a control diet, and analyzed their microbial communities using 16S rRNA amplicon sequencing. More...
They found that Triclosan was associated with rapid shifts in microbiome structure and diversity. They also found that operational taxonomic units (OTUs) associated with the Enterobacteriaceae were susceptible to triclosan exposure, while OTUs associated with Pseudomonas appeared to be more resilient.

The researchers also found that triclosan was associated an overall increase in the number of negative topological interactions per microbe. Together, the data indicates that triclosan exposure results in altered composition and ecological dynamics of microbial communities in the gut. The researchers clarified that although health implications are unclear, dysfunction of the gut microbiome has been associated with diabetes, heart disease, arthritis, and malnutrition. The study was published on May 18, 2016, in PLOS One.

“Clearly there may be situations where antibacterial agents are needed. However, scientists now have evidence that intestinal bacteria may have metabolic, cardiovascular, autoimmune and neurological impacts, and concerns about overuse of these agents are valid,” said lead author Christopher Gaulke, PhD, of the OSU College of Science. “Cumulative impacts are also possible. We need to do significantly more evaluation of their effects, some of which might be dramatic and long lasting.”

“There has been a legacy of concern about exposure to microbial pathogens, which has led to increased use of these antimicrobial products. There is now a growing awareness of the importance of the bacteria in our gut microbiome for human health,” added corresponding author Thomas Sharpton, PhD. “Overuse of antibiotics can lead to the rise of ‘superbugs.’ There are consequences to constantly trying to kill the bacteria in the world around us, aspects we’re just beginning to understand.”

Triclosan is a polychloro phenoxy phenol antibacterial and antifungal agent found in numerous consumer products and in health care settings, such as in surgical scrubs and personnel hand washes. Showering or bathing with a 2% triclosan solution has become a recommended regimen in surgical units for the decolonization of patients whose skin is carrying methicillin-resistant Staphylococcus aureus (MRSA). On the negative side, triclosan has been found to decrease circulating levels of thyroxine hormone (T4), which could lead to altered behavior, learning disabilities, and/or infertility.

Related Links:
Oregon State University


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.